Business Wire › March 23, 2001
Linked as:Extract
Antisense Research Identifies NEUGENE Compound's Success as a Potent Anti-Cancer Agent.
Business Editors, Health/Medical Writers
PORTLAND, Ore.--(BW HealthWire)--March 23, 2001 AVI BioPharma, Inc. (Nasdaq:AVII) (Nasdaq:AVIIW, AVIIZ) announced today that one of its gene-targeted th...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
challenge taken ; hornets tighten up defense | Milestone Defines Moreno s Brilliance | [World Review] | Northwest Airlink Pinnacle Pilots Open Strike Operations Center | Lo Scrittoio di Anthony Collins 1676-1729 I Libri e I Tempi di un Libero Pe... | Resolución nº 168290, de Corte de Apelaciones de Santiago - Sala -*-, September 08, 2009 | COMUNICATO Modificazione dell autorizzazione all immissione in commercio del medicinale per uso umano «Fostimon» 09A11859 | Sentencia nº 4226 de Consiglio di Stato, August 26, 2009
